Elizabeth A Sugar

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. pmc Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography
    Elizabeth A Sugar
    Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Am J Ophthalmol 152:1044-1052.e5. 2011
  2. pmc Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Elizabeth A Sugar
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21204, USA
    Am J Ophthalmol 153:1016-24.e5. 2012
  3. pmc Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial
    Kevin D Frick
    Department of Health Policy and Management, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Invest Ophthalmol Vis Sci 53:1169-76. 2012
  4. doi request reprint Risk factors for montelukast treatment failure in step-down therapy for controlled asthma
    M Bradley Drummond
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    J Asthma 48:1051-7. 2011

Collaborators

Detail Information

Publications4

  1. pmc Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography
    Elizabeth A Sugar
    Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Am J Ophthalmol 152:1044-1052.e5. 2011
    ..To identify a clinically meaningful threshold for change in retinal thickness measured by optical coherence tomography for patients with uveitic macular edema using correlation with change in visual acuity...
  2. pmc Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Elizabeth A Sugar
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21204, USA
    Am J Ophthalmol 153:1016-24.e5. 2012
    ..To estimate the incidence of cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy (HAART) and to characterize the factors associated with increased risk of CMV retinitis...
  3. pmc Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial
    Kevin D Frick
    Department of Health Policy and Management, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Invest Ophthalmol Vis Sci 53:1169-76. 2012
    ....
  4. doi request reprint Risk factors for montelukast treatment failure in step-down therapy for controlled asthma
    M Bradley Drummond
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    J Asthma 48:1051-7. 2011
    ..Because some patients fail montelukast step-down therapy, it would be helpful for clinicians to be able to predict the risk of treatment failure...